Aster Insights
Xin Lu has a vast and diverse work experience in the field of data science, bioinformatics, and computational biology. They are currently serving as the Director of Data Science, Quality, and Analytics at Aster Insights, where they handle internal data operations, processing pipeline, quality control, and improvement. Xin also collaborates with biotech, pharmaceutical, and academic institutions to utilize oncology real-world clinical and genomic data generated from the ORIEN network.
Before joining Aster Insights, they worked at AbbVie as a Senior Principal Research Scientist, where they led a team of bioinformaticians supporting oncology research and development programs. Xin played a critical role in the strategic development of genomic technology and analytical pipelines, internal/external collaborations, and the integration of diverse data sources. They also carried out data mining and genomic analysis for oncology target discovery and validation, as well as the development of translational biomarker strategies for clinical trials.
Prior to AbbVie, Xin served as a Senior Research Scientist at Abbott Laboratories, contributing to research projects until 2012. They also held positions at UC San Diego as an Assistant Professor, focusing on computational biology and biostatistics methodologies, and at Harvard School of Public Health as a Research Scientist, specializing in the development of computational biology and biostatistics methodologies in the context of cancer research.
Overall, Xin Lu's work experience showcases their expertise in data analysis, bioinformatics, and computational biology, along with their significant contributions to the field of oncology research and development.
Xin Lu obtained a Ph.D. in Bioinformatics from Tsinghua University, completing the degree between 1996 and 2001.
This person is not in any offices
Aster Insights
We believe that personalized medicine starts with a complete view of an individual across their lifetime. Our company was founded in 2006 on the unique principle that informed consent from patients entrusting us with a lifetime connection to their health information, paired with deep partnerships across academia and the life sciences industry, would unlock critical advances in curing cancer. Aster Insights leads the Oncology Research Information Exchange Network (ORIEN®), a consortium of the nation’s leading academic cancer centers that conduct Total Cancer Care®, the world’s largest and longest running observational research study in oncology. TCC® serves as the foundation for novel insights that power oncology breakthroughs. As a long-time innovator in oncology, Aster Insights has world-class expertise in accelerating the life cycle of oncology medical product development. Our solutions are based on scientific and clinical intelligence and strengthened by our unique partnership with patients, academia, and industry. We empower our partners to uncover new targets and biomarkers, enhance cancer detection, deepen our understanding of new treatments, discover new indications, and accelerate clinical trials. Together, we are changing the way cancer is studied, treated, and prevented.